MannKind Corporation has grown revenue 36% a year over three years and 40% a year over five. Revenue growth, 3-year annual rate: +36% (Biotechnology median +17%). Revenue growth, 5-year rate: +40%, growth has slowed since the five-year average. Years of annual history on file: 34, FY1991 to FY2025, as filed.

MNKDMannKind Corporation

Healthcare

$3.29-39% 1Y

$3.29

$2.2852 weeks$6.21

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +30% year on year, but operating margin narrowing (−18.5 points).

1 good, 1 to watch, 1 without data

Revenue trend+30% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +39% a year.

Margin direction−18.5 points operating

Trailing-twelve-month operating margin, 3.5% now against 22.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is MNKD growing?

MannKind Corporation has grown revenue 36% a year over three years and 40% a year over five.

+36%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +40%
Revenue growth, 5-year rate · +36% over three · growth has slowed since the five-year average
Years of annual history on file: 34
Years of annual history on file · FY1991 to FY2025, as filed

Details›